Bispecifics Drug Product Development; Challenge of Low Concentration Analysis and Formulation

11:50 - 12:25

  • Glenmark’s BEAT format – advantages, flexibilities, applicability etc.
  • Formulation and stability aspects of bispecifics.
  • Strategies to overcome analytical and formulation challenges for a highly potent molecule.
  • Preparation for clinical trials for extremely low FIH starting dose.

Sachin Dubey, Head of Formulation and Analytical Development, Glenmark